Navigation Links
Kansas Bioscience Authority Approves $700,000 in Investments
Date:11/20/2012

OLATHE, Kan., Nov. 20, 2012 /PRNewswire/ -- The Kansas Bioscience Authority board of directors today approved $700,000 in new investments. The investments are:

  • Parnell, an Australian veterinary pharmaceutical company, received a $400,000 grant to support the company's move to establish a North American headquarters in the Kansas City Animal Health Corridor. The grant will help to defray the company's hiring during the next year of 14 new employees with an average annual wage of $150,000.
  • A $300,000 grant will support the establishment in Kansas of a contract research organization by a firm established elsewhere in the country. The company expects to create 16 new jobs at its proposed Kansas site, with an average salary of $65,000 a year, as well as to attract new federal, state and privately funded research projects. The company also plans to work with Kansas research institutions to advance research and commercialization activities. The KBA has agreed to hold confidential the identity of the company pending the completion of certain negotiations related to its relocation to Kansas.

Approved investments are subject to final agreements between the Kansas Bioscience Authority and investees, with payments made only as the recipients achieve specified milestones.

About the KBA
The Kansas Bioscience Authority was created by the Kansas Economic Growth Act of 2004 to accelerate growth in the bioscience sector. Funded by Kansas income taxes generated by bioscience jobs, KBA investments help create high-paying jobs, fuel capital expenditures, spur outside grants, and encourage private capital investments in Kansas bioscience companies. KBA investments result in high-quality jobs today and for future generations of Kansans, and bioscience discoveries and life-saving cures that will improve lives around the world.

For more information, contact:
Justin LaBerge, APR
785.766.5688 (mobile) or justin@sturgesword.com


'/>"/>
SOURCE Kansas Bioscience Authority
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Kansas Bioscience Authority Announces FY11 Outcomes of $207 Million
2. Auditors Complete Kansas Bioscience Authority Forensic Audits
3. Netsmart Selects Overland Park, Kansas, for New Office
4. Heartland Plant Innovations Wins Kansas Bioscience Authority Funding
5. Cantrell Selected to Lead Kansas Bioscience Authority
6. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
7. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
8. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
9. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
10. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
11. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... During ... connected digital health applications, announced a partnership with Redox, a leader in cloud-based ... to many clinical systems while keeping data secure in the cloud. , The ...
(Date:2/21/2017)... ... 2017 , ... The medical potential of stem cells is both extensive and ... due to their differentiating characteristics. Stem cells are unique as the have the potential ... to become tissue or organic-specific cells with special functions. , Stem cell therapy ...
(Date:2/21/2017)... and VANCOUVER, British Columbia , Feb. ... ) today announced that apatorsen results from two randomized Phase ... Clinical Oncology (ASCO) 2017 Genitourinary Cancers Symposium, held February 16 ... . Clinical data from trials in bladder and prostate cancers ... in combination with standard-of-care treatments. ...
(Date:2/21/2017)... , Feb. 21, 2017   Invitae Corporation ... information companies, today announced that members of the company,s ... 37th Annual Health Care Conference on Monday, March 6, ... Pacific in Boston, Massachusetts . ... may be accessed by visiting the investors section of ...
Breaking Biology Technology:
(Date:2/7/2017)... 7, 2017   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... innovative, highly flexible and award winning eClinical solution, is ... iMedNet is a proven Software-as-a-Service (SaaS) clinical research ... (EDC), but also delivers an entire suite of eClinical ...
(Date:2/7/2017)... 7, 2017 Ipsidy Inc. ( ... [OTC: IDGS], ("Ipsidy" or the "Company") a provider of ... services, is pleased to announce the following changes as ... Effective January 31, 2017, Philip D. Beck ... and President.  An experienced payment industry professional and public ...
(Date:2/3/2017)... -- Texas Biomedical Research Institute announced that its Board of Trustees ... the Institute,s new President and CEO. Dr. Schlesinger will take ... is currently the Chair of the Department of Microbial Infection ... Biology at Ohio State University. "We are delighted ... of Texas Biomed," said Dr. James O. Rubin , ...
Breaking Biology News(10 mins):